Provided by Tiger Trade Technology Pte. Ltd.

ZHONGZHIPHARM

0.780
+0.0202.63%
Volume:407.00K
Turnover:313.69K
Market Cap:673.92M
PE:39.00
High:0.780
Open:0.745
Low:0.745
Close:0.760
52wk High:0.980
52wk Low:0.500
Shares:864.00M
HK Float Shares:863.60M
Volume Ratio:0.95
T/O Rate:0.05%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.020
ROE:1.63%
ROA:0.47%
PB:0.52
PE(LYR):39.00
PS:0.35

Loading ...

Zhongzhi Pharmaceutical Reports No Change in Share Capital for September 2026; Public Float Remains Compliant

Bulletin Express
·
Oct 02

ZHONGZHIPHARM Releases 2026 Interim Report and Sets Out Digital Communication Options

Bulletin Express
·
Sep 16

Zhongzhi Pharmaceutical 1H26 Revenue Falls 10.3%, Net Profit Up 3.8% on Cost Controls

Bulletin Express
·
Sep 16

Zhongzhi Pharmaceutical Maintains Stable Share Capital and Public Float in August 2026

Bulletin Express
·
Sep 01

Chinese Traditional Medicine Maker Tong Ren Tang Profit Falls on Weaker Demand

Reuters
·
Aug 28

China's Dawnrays Pharmaceutical H1 Revenue Falls on Lower Procurement Prices

Reuters
·
Aug 28

China's Kindstar Globalgene H1 Loss Narrows After Oncology Testing Expansion

Reuters
·
Aug 27

China's Zhongzhi Pharmaceutical H1 Revenue Falls 10%

Reuters
·
Aug 26

Zhongzhi Pharm Posts Interim Results with 3.79% Rise in Net Profit Attributable to Shareholders

Stock News
·
Aug 26

Zhongzhi Pharma FY26 H1 Profit Attributable to Owners Rises 3.8% to RMB 9.1 Million; Revenue Falls 10.3% to RMB 790 Million

Reuters
·
Aug 26

Zhongzhi Pharmaceutical Holdings H1 Net Income Attributable RMB 9.1 Million

THOMSON REUTERS
·
Aug 26

ZHONGZHIPHARM Sets 26 Aug 2026 Board Meeting to Review H1 2026 Results and Interim Dividend

Bulletin Express
·
Aug 14

Zhongzhi Pharmaceutical Schedules Board Meeting to Review Interim Results, Dividend Plan

Reuters
·
Aug 14

Zhongzhi Pharmaceutical Affirms Stable Share Base and Compliance with Public Float in May 2026

Bulletin Express
·
Jun 01

Zhongzhi Pharmaceutical held annual shareholder meeting, resolutions passed by vote

Reuters
·
May 13

Zhongzhi Pharm Maintains Stable Share Capital and Meets Public Float Requirement in April 2026

Bulletin Express
·
May 04

Zhongzhi Pharmaceutical Holdings' (HKG:3737) Weak Earnings May Only Reveal A Part Of The Whole Picture

Simply Wall St.
·
Apr 28

ZHONGZHIPHARM Publishes 2025 Annual Report, Issues AGM Notice for 13 May 2026

Bulletin Express
·
Apr 20

中智药业2025年业绩下滑 生产与零售两大板块调整加速

Bulletin Express
·
Apr 20

Zhongzhi Pharma Calls 13 May 2026 AGM; Seeks 10% Buy-back Mandate, 20% Issuance Capacity and Board Re-elections

Bulletin Express
·
Apr 20